860569 | C17 Glucosyl(ß) Ceramide (d18:1/17:0)
D-glucosyl-ß-1,1'-N-heptadecanoyl-D-erythro-sphingosine
Please Confirm Your Location
Effective March 1, 2018, Merck KGaA, Darmstadt, Germany* is the exclusive Distributor of Avanti Research. Research Products for all countries except the United States. For product pricing and order placement, please click on the appropriate Location Box below.
For customers located outside the United States, you will be redirected to www.sigmaaldrich.com/avanti prior to completing your purchase. Thank you for your continued business and support of Avanti Research!
*The life science business of Merck KGaA, Darmstadt, Germany operates as MilliporeSigma in the U.S. and Canada
C17 Glucosyl(ß) Ceramide (d18:1/17:0)
D-glucosyl-ß-1,1'-N-heptadecanoyl-D-erythro-sphingosine
CAS Registry Number is a Registered Trademark of the American Chemical Society
Powered by BiozRossi C, Cicalini I, Zucchelli M, di Ioia M, Onofrj M, Federici L, Del Boccio P, Pieragostino D. Metabolomic Signature in Sera of Multiple Sclerosis Patients during Pregnancy. Int J Mol Sci. 2018 Nov 14;19(11). pii: E3589. doi: 10.3390/ijms19113589.
PubMed ID: 30441762- Certificate of Analysis (Lot No. 860569P-25MG-A-015 and 6013PJA015)
- Certificate of Analysis (Lot No. 860569P-5MG-A-015 and 6013PHA015)
- Certificate of Analysis (Lot No. 860569P-25MG-B-015 and 6013PJB015)
- Certificate of Analysis (Lot No. 860569P-5MG-B-015 and 6013PHB015)
- Certificate of Analysis (Lot No. 860569P-5MG-C-015 and 6013PHC015)
- Certificate of Analysis (Lot No. 860569P-5MG-D-015 and 6013PHD015)
- Certificate of Analysis (Lot No. 860569P-5MG-F-015 and 6013PHF015)
- Certificate of Analysis (Lot No. 860569P-5MG-E-015 and 6013PHE015)
- Certificate of Analysis (Lot No. 860569P-5MG-A-016 and 6013PHA016)
- Certificate of Analysis (Lot No. 860569P-5MG-B-016 and 6013PHB016)
- Certificate of Analysis (Lot No. 860569P-5MG-C-016 and 6013PHC016)
- Certificate of Analysis (Lot No. 860569P-5MG-D-016 and 6013PHD016)
